Eli Lilly and Company: Prostatic Hyperplasia trials

The registry lists 17 Prostatic Hyperplasia studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 16 have results posted.

Phase 1 1Phase 2 6Phase 3 10Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).CompletedNCT02431754Phase 4Results posted
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)CompletedNCT01937871Phase 3Results posted
• Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)CompletedNCT01460342Phase 3Results posted
• A Study of Tadalafil in Benign Prostatic HyperplasiaCompletedNCT01183650Phase 1Results posted
• A Study in Benign Prostatic HyperplasiaCompletedNCT01152190Phase 3Results posted
• A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary SymptomsCompletedNCT01139762Phase 3Results posted
• A Study in Men With Benign Prostatic HyperplasiaTerminatedNCT01097707Phase 2Results posted
• A Study of Tadalafil in Men With Benign Prostatic HyperplasiaCompletedNCT00970632Phase 3Results posted
• Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00861757Phase 3Results posted
• A Study in the Treatment of Erectile Dysfunction and Benign Prostate HyperplasiaCompletedNCT00855582Phase 3Results posted
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha BlockersCompletedNCT00848081Phase 3Results posted
• Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil DailyCompletedNCT00827242Phase 3Results posted
• Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label ExtensionCompletedNCT00783094Phase 2Results posted
• Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian MenCompletedNCT00540124Phase 2Results posted
• Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00386009Phase 2Results posted
• Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00384930Phase 2/3Results posted
• Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract ProblemsCompletedNCT00547625Phase 2